OUR FOCUS

Developing next generation peptide therapeutics for obesity and liver disease

OUR PROGRAMS

liver icon
Peptide-Based Therapeutics for Obesity and Liver Diseases
Intranasal vaccines for Anthrax and Influenza - icon
Intranasal Vaccines & Therapeutics for Anthrax, Influenza and COVID-19

OUR PIPELINE

Our diverse pipeline includes treatments for obesity, NASH (ALT-801), and chronic Hepatitis B (HepTcell™). In addition, we are developing intranasal vaccine & therapeutic candidates for anthrax, influenza and COVID-19.

OBESITY AND LIVER THERAPIES

liver therapies iconALT-801
liver therapies iconHepTcell™

INTRANASAL VACCINES & THERAPEUTICS

intranasal vaccines iconNasoVAX™
intranasal vaccines iconNasoShield™
intranasal vaccines iconT-COVID™
VIEW PIPELINE